Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Moleculin Biotech Inc
MBRXCurrent price
2.43 USD
0 USD (0.00%)
Last closed
2.43 USD
Company
www.moleculin.com
ISIN
US60855D2009
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
6 826 872 USD
Yield for 12 month
-57.92 %
1Y
3Y
5Y
10Y
15Y
MBRX
Moleculin Biotech, Inc., a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses. Its lead drug candidate is Annamycin, which is in Phase 1B/2 clinical trials for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma metastasized to the lungs. The company is also developing WP1066, an immune/transcription modulator designed to inhibit phosphorylated signal transducer and activator of transcription and other oncogenic transcription factors targeting brain tumors, and pancreatic and other cancers. In addition, it develops WP1220, an analog of WP1066 for the topical treatment of cutaneous T-cell lymphoma; and WP1122 to treat viruses, as well as cancer indications, including brain tumors, and pancreatic and other cancers. The company was incorporated in 2015 and is headquartered in Houston, Texas. Address: 5300 Memorial Drive, Houston, TX, United States, 77007
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
31.67 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+406 000 USD
Current Year
-127 000 USD
Last Year
-222 000 USD
Current Quarter
-31 000 USD
Last Quarter
-32 000 USD
Key Figures MBRX
1 year
3 years
5 years
10 years
EBITDA
-27 598 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-47.68 %
PEG Ratio
–
Return On Equity TTM
-86.82 %
Wall Street Target Price
31.67 USD
Revenue TTM
–
Book Value
6.91 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-11.73 USD
Diluted Eps TTM
-11.73 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics MBRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MBRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
22.03.2024
Dividend Date
01.02.2021
Stock Valuation MBRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.5229
Price Book MRQ
0.3856
Financials MBRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MBRX
For 52 weeks
2.12 USD
15.75 USD
50 Day MA
3.03 USD
Shares Short Prior Month
27 932
200 Day MA
2.56 USD
Short Ratio
1.14
Shares Short
51 331
Short Percent
2.07 %
BeatStart